Cargando…

Proteomics and genomics: perspectives on drug and target discovery

Detalles Bibliográficos
Autores principales:	Ahn, Natalie G, Wang, Andrew H-J
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386992/ https://www.ncbi.nlm.nih.gov/pubmed/18302945 http://dx.doi.org/10.1016/j.cbpa.2008.02.016

Ejemplares similares

An omics perspective on drug target discovery platforms
por: Paananen, Jussi, et al.
Publicado: (2019)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
por: Hedl, Thomas J., et al.
Publicado: (2019)

Genomic and Proteomic Biomarker Discovery in Neurological Disease
por: Robeson, RiLee H., et al.
Publicado: (2008)

The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery
por: Savino, Rocco, et al.
Publicado: (2012)

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021)

Strategies for translating proteomics discoveries into drug discovery for dementia
por: Halder, Aditi, et al.
Publicado: (2023)

Rapid empirical discovery of optimal peptides for targeted proteomics
por: Stergachis, Andrew B., et al.
Publicado: (2011)

Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
por: Jiang, Guoqian, et al.
Publicado: (2015)

Targeted Drug Discovery for Pediatric Leukemia
por: Napper, Andrew D., et al.
Publicado: (2013)

Functional genomics for breast cancer drug target discovery
por: Yoshimaru, Tetsuro, et al.
Publicado: (2021)

Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics
por: Gianazza, Erica, et al.
Publicado: (2020)

Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics
por: Hudler, Petra, et al.
Publicado: (2014)

Biomarker and Drug Target Discovery Using Quantitative Proteomics Post-Intracerebral Hemorrhage Stroke in the Rat Brain
por: Deng, Shuixiang, et al.
Publicado: (2018)

Advances in the proteomic discovery of novel therapeutic targets in cancer
por: Guo, Shanchun, et al.
Publicado: (2013)

A perspective on multi-target drug discovery and design for complex diseases
por: Ramsay, Rona R., et al.
Publicado: (2018)

Drug–Target Kinetics in Drug Discovery
por: Tonge, Peter J.
Publicado: (2017)

Proteomics in Biomarker Discovery for Tuberculosis: Current Status and Future Perspectives
por: Guo, Jiubiao, et al.
Publicado: (2022)

Genomic approaches to drug target discovery using mouse models
por: Morris, DW
Publicado: (2003)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
por: Amiri-Dashatan, Nasrin, et al.
Publicado: (2018)

Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics
por: Piggott, Andrew M., et al.
Publicado: (2005)

Astrocytes as targets for drug discovery
por: Gorshkov, Kirill, et al.
Publicado: (2018)

Moving targets in drug discovery
por: Zdrazil, Barbara, et al.
Publicado: (2020)

Targeting cancer stem cells in drug discovery: Current state and future perspectives
por: Du, Fang-Yu, et al.
Publicado: (2019)

A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery
por: Venkatesan, Janarthanan, et al.
Publicado: (2022)

RNA-targeted small-molecule drug discoveries: a machine-learning perspective
por: Xiao, Huan, et al.
Publicado: (2023)

Protozoan genomics for drug discovery
por: Chaudhary, Kshitiz, et al.
Publicado: (2005)

Genomes2Drugs: Identifies Target Proteins and Lead Drugs from Proteome Data
por: Toomey, David, et al.
Publicado: (2009)

TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
por: Borcherding, Dana C., et al.
Publicado: (2021)

Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery
por: Tanase, Cristiana Pistol, et al.
Publicado: (2017)

Prioritization of Molecular Targets for Antimalarial Drug Discovery
por: Forte, Barbara, et al.
Publicado: (2021)

Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery
por: dos Santos Vasconcelos, Crhisllane Rafaele, et al.
Publicado: (2021)

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
por: Belbin, Olivia, et al.
Publicado: (2020)

Protein-Targeting Drug Discovery
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Structural genomics and drug discovery
por: Lundstrom, K
Publicado: (2007)

Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules
por: Moore, Kendall B. E., et al.
Publicado: (2023)

Targeting GTPases in Parkinson’s disease: comparison to the historic path of kinase drug discovery and perspectives
por: Hong, Lin, et al.
Publicado: (2014)

STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape
por: Kong, Xiangjun, et al.
Publicado: (2022)

Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery
por: Kim, Hyun Uk, et al.
Publicado: (2011)

Proteomics for the discovery of nuclear bile acid receptor FXR targets()
por: Gardmo, Cissi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6n1fkhaj642mllharbkg5pdu09